APR 22, 2020 11:39 AM PDT

Microneedle Skin Patch Collects Bodily Fluids for On-patch Diagnostic Testing

WRITTEN BY: Lawrence Renna

The collection of blood for diagnostic tests is common practice in clinical settings. However, technicians often need to separate plasma from serum, which adds additional time and complexity to the process. Also, many patients are terrified of needles being stuck in their veins. Therefore, when it comes to diagnostic testing, a simple new method that avoids using needles and drawing blood would benefit the field of clinical diagnostics. New research out of the George Institute of Technology and Washington University published in ACS Sensors details the development of a microneedle patch that painlessly attaches to the patient’s skin and collects interstitial fluid (ISF) for on-patch point-of-care diagnostic testing.

ISF is a bodily fluid that fills the interstitial space between cells. ISF contains many of the same biomarkers that are also present in the blood. However, ISF can be simpler to use in diagnostic testing than blood because it does not contain any cells or clotting agents. Patches that contain microneedles can collect ISF from the skin. Remarkably, the needles are so small that patients do not feel any pain when it is attached to their skin. Until now, the ISF collected from microneedles needs to undergo complicated multistep processes, such as biomarker extraction, centrifugation, sample loading, and analysis for diagnostic testing.

The microneedle patch developed by Srikanth Singamaneni, Mark Prausnitz, and colleagues collects ISF from the skin and delivers it to plasmonic paper containing gold nanorods. Diagnostic testing can be performed directly on the patch’s plasmonic paper in a single step. This improvement dramatically reduces the time and complexity of ISF diagnostic testing. The mechanism of detection is called surface-enhanced Raman scattering (SERS), a phenomenon in which absorbed molecules modulate the scattering of light by metal nanostructures. SERS has the capability to enhance the signal of the molecule of interest greater than 10 billion times, which makes single-molecule detection a possibility in the future. As a proof-of-principle, the researchers were able to detect dye that was injected into rats in their ISF using SERS.

 

 

Sources: American Chemical Society, ACS Sensors, and The Journal of the American Chemical Society

About the Author
  • Hello! I am a scientist currently living in Southern California, although I am originally from the east coast. I received my B.S. in Chemistry from Northeastern University in 2012, and my Ph.D. in Chemistry from the University of Massachusetts Amherst. I also had a postdoctoral appointment at the University of California, Irvine. I have written 25+ peer-reviewed articles, several patents, and one book chapter. I am a reviewer for scientific manuscripts, and a freelance editor and writer. Outside of science, I enjoy spending time with my family, training Jiu-Jitsu, and baking sourdough bread. I am happy to be writing for LabRoots.
You May Also Like
JUN 08, 2021
Genetics & Genomics
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
JUN 08, 2021
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
Today, many scientists are investigating SARS-CoV-2 variants in their research projects. In order to facilitate screenin ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUL 15, 2021
Clinical & Molecular DX
Childhood Lead Exposure Influences Personality in Adulthood
JUL 15, 2021
Childhood Lead Exposure Influences Personality in Adulthood
Exposure to toxic chemicals in childhood could have unlikely effects on personality, and behavioral traits in adulthood, ...
AUG 17, 2021
Clinical & Molecular DX
Delays in Breast Cancer Diagnoses Among Black Women
AUG 17, 2021
Delays in Breast Cancer Diagnoses Among Black Women
Thanks to breakthrough diagnostic technologies, we can now catch the early warning signs of breast cancer much faster th ...
SEP 23, 2021
Clinical & Molecular DX
Skin Microbiome Analysis Gets Cleaned Up
SEP 23, 2021
Skin Microbiome Analysis Gets Cleaned Up
  Our skin is home to a carnival of millions of bacteria, fungi, and viruses that together form the dermal microbio ...
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
Loading Comments...